Post-market Clinical Follow-up Study of NEMOST V2 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Post-market Clinical Follow-up Study of NEMOST V2 — Stella

Home/Scoliosis Neuromuscular/

View on ClinicalTrials.gov

Recruiting

Back to Scoliosis Neuromuscular trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(5 sites)

France

Hopital Lenval Nice, Nice, Provence-Alpes-Côte d'Azur Region

CHU Pellegrin, Bordeaux

Hospices Civils de Lyon, Lyon

Hopital Armand Trousseau, Paris

Hopital Necker, Paris

Key details

Sponsor

EUROS

Enrollment target

~140 participants

Started

December 2025

Primary completion

December 2033

Age range

5 Years – 17 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.